Logo-ijhpm
Int J Health Policy Manag. 2022;11(9): 1625-1634. doi: 10.34172/ijhpm.2021.138
PMID: 34814670        PMCID: PMC9808218

Systematic Review

Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature

Chanthawat Patikorn 1 ORCID, Suthira Taychakhoonavudh 1, Rungpetch Sakulbumrungsil 1 ORCID, Dennis Ross-Degnan 2 ORCID, Puree Anantachoti 1 * ORCID

Cited by CrossRef:

1- Hwang S, Jang Y, Lim K, Jung J, Lee J. New drug accessibility and budgetary impact in South Korea: policy challenges and implications. Expert Review of Pharmacoeconomics & Outcomes Research. 2025;:1 [Crossref]
2- Yang Y, Zhang Y, Wagner A, Li H, Shi L, Guan X. The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data. J Glob Health. 2023;13 [Crossref]